nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HRH4—stomach cancer	0.544	0.776	CbGaD
Mianserin—HTR1A—stomach cancer	0.157	0.224	CbGaD
Mianserin—HRH2—gastric juice—stomach cancer	0.0156	0.207	CbGeAlD
Mianserin—HTR7—myenteric nerve plexus—stomach cancer	0.00637	0.0849	CbGeAlD
Mianserin—HTR7—vagus nerve—stomach cancer	0.00425	0.0566	CbGeAlD
Mianserin—HTR7—vein—stomach cancer	0.00411	0.0547	CbGeAlD
Mianserin—HTR2A—myenteric nerve plexus—stomach cancer	0.00397	0.0529	CbGeAlD
Mianserin—HRH4—hematopoietic system—stomach cancer	0.00325	0.0433	CbGeAlD
Mianserin—HTR2A—vagus nerve—stomach cancer	0.00265	0.0353	CbGeAlD
Mianserin—HTR2A—vein—stomach cancer	0.00256	0.0341	CbGeAlD
Mianserin—HRH4—bone marrow—stomach cancer	0.00208	0.0278	CbGeAlD
Mianserin—HTR1D—blood vessel—stomach cancer	0.00164	0.0218	CbGeAlD
Mianserin—HRH2—hematopoietic system—stomach cancer	0.00136	0.0182	CbGeAlD
Mianserin—HTR7—blood vessel—stomach cancer	0.0013	0.0174	CbGeAlD
Mianserin—HRH2—digestive system—stomach cancer	0.000949	0.0126	CbGeAlD
Mianserin—SLC6A3—hematopoietic system—stomach cancer	0.000892	0.0119	CbGeAlD
Mianserin—SLC6A4—hematopoietic system—stomach cancer	0.000818	0.0109	CbGeAlD
Mianserin—HTR2A—blood vessel—stomach cancer	0.000812	0.0108	CbGeAlD
Mianserin—HRH2—endocrine gland—stomach cancer	0.000784	0.0104	CbGeAlD
Mianserin—HTR1A—hematopoietic system—stomach cancer	0.000726	0.00967	CbGeAlD
Mianserin—HTR2B—smooth muscle tissue—stomach cancer	0.000714	0.00951	CbGeAlD
Mianserin—HRH2—liver—stomach cancer	0.000707	0.00942	CbGeAlD
Mianserin—HTR7—hematopoietic system—stomach cancer	0.000694	0.00924	CbGeAlD
Mianserin—HTR7—epithelium—stomach cancer	0.000634	0.00845	CbGeAlD
Mianserin—HTR7—smooth muscle tissue—stomach cancer	0.000611	0.00814	CbGeAlD
Mianserin—SLC6A4—digestive system—stomach cancer	0.000569	0.00757	CbGeAlD
Mianserin—HTR2B—digestive system—stomach cancer	0.000563	0.0075	CbGeAlD
Mianserin—CYP1A2—hematopoietic system—stomach cancer	0.000553	0.00737	CbGeAlD
Mianserin—HRH2—lymph node—stomach cancer	0.000542	0.00722	CbGeAlD
Mianserin—CYP2B6—hematopoietic system—stomach cancer	0.00053	0.00707	CbGeAlD
Mianserin—ADRA2C—pancreas—stomach cancer	0.000519	0.00692	CbGeAlD
Mianserin—HRH1—hematopoietic system—stomach cancer	0.000518	0.0069	CbGeAlD
Mianserin—ADRA2A—hematopoietic system—stomach cancer	0.000509	0.00678	CbGeAlD
Mianserin—HTR7—digestive system—stomach cancer	0.000482	0.00643	CbGeAlD
Mianserin—HRH1—epithelium—stomach cancer	0.000473	0.00631	CbGeAlD
Mianserin—SLC6A4—endocrine gland—stomach cancer	0.00047	0.00626	CbGeAlD
Mianserin—HRH1—smooth muscle tissue—stomach cancer	0.000456	0.00608	CbGeAlD
Mianserin—CYP2B6—Irinotecan—stomach cancer	0.000454	0.326	CbGbCtD
Mianserin—Amitriptyline—HRH4—stomach cancer	0.000444	0.142	CrCbGaD
Mianserin—HTR2A—hematopoietic system—stomach cancer	0.000433	0.00576	CbGeAlD
Mianserin—HTR1A—endocrine gland—stomach cancer	0.000417	0.00556	CbGeAlD
Mianserin—ADRA2A—pancreas—stomach cancer	0.000414	0.00552	CbGeAlD
Mianserin—SLC6A2—endocrine gland—stomach cancer	0.000414	0.00551	CbGeAlD
Mianserin—CYP3A4—hematopoietic system—stomach cancer	0.0004	0.00533	CbGeAlD
Mianserin—HTR7—endocrine gland—stomach cancer	0.000399	0.00531	CbGeAlD
Mianserin—HTR2A—epithelium—stomach cancer	0.000395	0.00527	CbGeAlD
Mianserin—CYP2D6—hematopoietic system—stomach cancer	0.000394	0.00525	CbGeAlD
Mianserin—CYP1A2—digestive system—stomach cancer	0.000385	0.00513	CbGeAlD
Mianserin—HTR2A—smooth muscle tissue—stomach cancer	0.000381	0.00508	CbGeAlD
Mianserin—DRD2—endocrine gland—stomach cancer	0.000377	0.00502	CbGeAlD
Mianserin—CYP2B6—lymphoid tissue—stomach cancer	0.000373	0.00497	CbGeAlD
Mianserin—CYP2B6—digestive system—stomach cancer	0.000369	0.00491	CbGeAlD
Mianserin—HRH1—digestive system—stomach cancer	0.00036	0.0048	CbGeAlD
Mianserin—HTR7—liver—stomach cancer	0.000359	0.00479	CbGeAlD
Mianserin—ADRA2C—liver—stomach cancer	0.00033	0.0044	CbGeAlD
Mianserin—HTR2B—lymph node—stomach cancer	0.000322	0.00429	CbGeAlD
Mianserin—CYP1A2—endocrine gland—stomach cancer	0.000318	0.00424	CbGeAlD
Mianserin—Mirtazapine—ADRB1—stomach cancer	0.000314	0.101	CrCbGaD
Mianserin—CYP2B6—endocrine gland—stomach cancer	0.000305	0.00406	CbGeAlD
Mianserin—HTR2A—digestive system—stomach cancer	0.000301	0.00401	CbGeAlD
Mianserin—HRH1—endocrine gland—stomach cancer	0.000298	0.00396	CbGeAlD
Mianserin—ADRA2A—endocrine gland—stomach cancer	0.000292	0.00389	CbGeAlD
Mianserin—CYP1A2—liver—stomach cancer	0.000287	0.00382	CbGeAlD
Mianserin—SLC6A2—lymph node—stomach cancer	0.000286	0.00381	CbGeAlD
Mianserin—Lethargy—Epirubicin—stomach cancer	0.000284	0.00302	CcSEcCtD
Mianserin—Confusional state—Fluorouracil—stomach cancer	0.000284	0.00302	CcSEcCtD
Mianserin—Bradycardia—Capecitabine—stomach cancer	0.000282	0.003	CcSEcCtD
Mianserin—Mirtazapine—HTR1A—stomach cancer	0.000281	0.0901	CrCbGaD
Mianserin—Oedema—Fluorouracil—stomach cancer	0.000281	0.00299	CcSEcCtD
Mianserin—Connective tissue disorder—Docetaxel—stomach cancer	0.000281	0.00299	CcSEcCtD
Mianserin—CYP3A4—digestive system—stomach cancer	0.000279	0.00371	CbGeAlD
Mianserin—Diplopia—Epirubicin—stomach cancer	0.000279	0.00296	CcSEcCtD
Mianserin—Hepatitis—Capecitabine—stomach cancer	0.000277	0.00294	CcSEcCtD
Mianserin—Nervous system disorder—Fluorouracil—stomach cancer	0.000276	0.00293	CcSEcCtD
Mianserin—Thrombocytopenia—Fluorouracil—stomach cancer	0.000275	0.00293	CcSEcCtD
Mianserin—CYP2B6—liver—stomach cancer	0.000275	0.00366	CbGeAlD
Mianserin—Tachycardia—Fluorouracil—stomach cancer	0.000274	0.00292	CcSEcCtD
Mianserin—Hypotension—Irinotecan—stomach cancer	0.000274	0.00292	CcSEcCtD
Mianserin—CYP2D6—digestive system—stomach cancer	0.000274	0.00365	CbGeAlD
Mianserin—Cyproheptadine—HTR1A—stomach cancer	0.000273	0.0874	CrCbGaD
Mianserin—Connective tissue disorder—Capecitabine—stomach cancer	0.000272	0.00289	CcSEcCtD
Mianserin—Breast disorder—Methotrexate—stomach cancer	0.000269	0.00286	CcSEcCtD
Mianserin—Eye disorder—Docetaxel—stomach cancer	0.000267	0.00284	CcSEcCtD
Mianserin—Cardiac disorder—Docetaxel—stomach cancer	0.000265	0.00282	CcSEcCtD
Mianserin—Cardiac arrest—Epirubicin—stomach cancer	0.000265	0.00282	CcSEcCtD
Mianserin—Mirtazapine—ADRB2—stomach cancer	0.000264	0.0847	CrCbGaD
Mianserin—Cardiac failure—Doxorubicin—stomach cancer	0.000264	0.00281	CcSEcCtD
Mianserin—Paraesthesia—Irinotecan—stomach cancer	0.000264	0.00281	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—stomach cancer	0.000263	0.0028	CcSEcCtD
Mianserin—Hypotension—Fluorouracil—stomach cancer	0.000263	0.0028	CcSEcCtD
Mianserin—Somnolence—Irinotecan—stomach cancer	0.000261	0.00278	CcSEcCtD
Mianserin—Angiopathy—Docetaxel—stomach cancer	0.000259	0.00276	CcSEcCtD
Mianserin—Eye disorder—Capecitabine—stomach cancer	0.000258	0.00275	CcSEcCtD
Mianserin—Tinnitus—Capecitabine—stomach cancer	0.000258	0.00274	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—stomach cancer	0.000258	0.00274	CcSEcCtD
Mianserin—Mediastinal disorder—Docetaxel—stomach cancer	0.000257	0.00274	CcSEcCtD
Mianserin—Cardiac disorder—Capecitabine—stomach cancer	0.000257	0.00273	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000256	0.00273	CcSEcCtD
Mianserin—CYP1A2—Fluorouracil—stomach cancer	0.000255	0.183	CbGbCtD
Mianserin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000253	0.0027	CcSEcCtD
Mianserin—ADRA2C—lymph node—stomach cancer	0.000253	0.00337	CbGeAlD
Mianserin—Fatigue—Irinotecan—stomach cancer	0.000253	0.00269	CcSEcCtD
Mianserin—Paraesthesia—Fluorouracil—stomach cancer	0.000252	0.00269	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—stomach cancer	0.000252	0.00268	CcSEcCtD
Mianserin—Constipation—Irinotecan—stomach cancer	0.000251	0.00267	CcSEcCtD
Mianserin—Angiopathy—Capecitabine—stomach cancer	0.000251	0.00267	CcSEcCtD
Mianserin—Mental disorder—Docetaxel—stomach cancer	0.00025	0.00266	CcSEcCtD
Mianserin—Somnolence—Fluorouracil—stomach cancer	0.00025	0.00266	CcSEcCtD
Mianserin—Mediastinal disorder—Capecitabine—stomach cancer	0.000249	0.00265	CcSEcCtD
Mianserin—HTR2A—endocrine gland—stomach cancer	0.000249	0.00331	CbGeAlD
Mianserin—CYP2B6—Doxorubicin—stomach cancer	0.000248	0.178	CbGbCtD
Mianserin—Cardiac arrest—Doxorubicin—stomach cancer	0.000245	0.00261	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—stomach cancer	0.000244	0.0026	CcSEcCtD
Mianserin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000243	0.00258	CcSEcCtD
Mianserin—Mental disorder—Capecitabine—stomach cancer	0.000242	0.00258	CcSEcCtD
Mianserin—Feeling abnormal—Irinotecan—stomach cancer	0.000242	0.00257	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—stomach cancer	0.000241	0.00256	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—stomach cancer	0.000237	0.00252	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—stomach cancer	0.000233	0.00248	CcSEcCtD
Mianserin—Feeling abnormal—Fluorouracil—stomach cancer	0.000232	0.00247	CcSEcCtD
Mianserin—CYP3A4—endocrine gland—stomach cancer	0.00023	0.00307	CbGeAlD
Mianserin—Anaemia—Docetaxel—stomach cancer	0.00023	0.00245	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—stomach cancer	0.000229	0.00244	CcSEcCtD
Mianserin—Pancytopenia—Epirubicin—stomach cancer	0.000229	0.00243	CcSEcCtD
Mianserin—CYP2D6—endocrine gland—stomach cancer	0.000226	0.00302	CbGeAlD
Mianserin—Tremor—Capecitabine—stomach cancer	0.000226	0.0024	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—stomach cancer	0.000225	0.0024	CcSEcCtD
Mianserin—HTR2A—liver—stomach cancer	0.000224	0.00299	CbGeAlD
Mianserin—Syncope—Docetaxel—stomach cancer	0.000223	0.00237	CcSEcCtD
Mianserin—Leukopenia—Docetaxel—stomach cancer	0.000223	0.00237	CcSEcCtD
Mianserin—Anaemia—Capecitabine—stomach cancer	0.000223	0.00237	CcSEcCtD
Mianserin—Weight increased—Epirubicin—stomach cancer	0.000219	0.00233	CcSEcCtD
Mianserin—Loss of consciousness—Docetaxel—stomach cancer	0.000219	0.00233	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—stomach cancer	0.000217	0.00231	CcSEcCtD
Mianserin—Vertigo—Capecitabine—stomach cancer	0.000216	0.0023	CcSEcCtD
Mianserin—Syncope—Capecitabine—stomach cancer	0.000216	0.0023	CcSEcCtD
Mianserin—Leukopenia—Capecitabine—stomach cancer	0.000216	0.00229	CcSEcCtD
Mianserin—Convulsion—Docetaxel—stomach cancer	0.000215	0.00229	CcSEcCtD
Mianserin—Hypertension—Docetaxel—stomach cancer	0.000215	0.00228	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—stomach cancer	0.000215	0.00228	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—stomach cancer	0.000214	0.00228	CcSEcCtD
Mianserin—Myalgia—Docetaxel—stomach cancer	0.000212	0.00225	CcSEcCtD
Mianserin—Arthralgia—Docetaxel—stomach cancer	0.000212	0.00225	CcSEcCtD
Mianserin—Loss of consciousness—Capecitabine—stomach cancer	0.000212	0.00225	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—stomach cancer	0.000212	0.00225	CcSEcCtD
Mianserin—Asthenia—Irinotecan—stomach cancer	0.000211	0.00224	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00021	0.00224	CcSEcCtD
Mianserin—Jaundice—Epirubicin—stomach cancer	0.000209	0.00223	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—stomach cancer	0.000208	0.00222	CcSEcCtD
Mianserin—Hypertension—Capecitabine—stomach cancer	0.000208	0.00221	CcSEcCtD
Mianserin—CYP3A4—liver—stomach cancer	0.000207	0.00276	CbGeAlD
Mianserin—Dry mouth—Docetaxel—stomach cancer	0.000207	0.0022	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—stomach cancer	0.000206	0.00219	CcSEcCtD
Mianserin—HRH1—lymph node—stomach cancer	0.000206	0.00274	CbGeAlD
Mianserin—Myalgia—Capecitabine—stomach cancer	0.000205	0.00218	CcSEcCtD
Mianserin—Arthralgia—Capecitabine—stomach cancer	0.000205	0.00218	CcSEcCtD
Mianserin—Confusional state—Docetaxel—stomach cancer	0.000205	0.00218	CcSEcCtD
Mianserin—CYP2D6—liver—stomach cancer	0.000204	0.00272	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000204	0.00217	CcSEcCtD
Mianserin—Hepatobiliary disease—Epirubicin—stomach cancer	0.000203	0.00216	CcSEcCtD
Mianserin—Oedema—Docetaxel—stomach cancer	0.000203	0.00216	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—stomach cancer	0.000203	0.00216	CcSEcCtD
Mianserin—ADRA2A—lymph node—stomach cancer	0.000202	0.00269	CbGeAlD
Mianserin—Dry mouth—Capecitabine—stomach cancer	0.0002	0.00213	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—stomach cancer	0.0002	0.00213	CcSEcCtD
Mianserin—Shock—Docetaxel—stomach cancer	0.0002	0.00213	CcSEcCtD
Mianserin—Nervous system disorder—Docetaxel—stomach cancer	0.000199	0.00212	CcSEcCtD
Mianserin—Pruritus—Fluorouracil—stomach cancer	0.000199	0.00212	CcSEcCtD
Mianserin—Thrombocytopenia—Docetaxel—stomach cancer	0.000199	0.00211	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—stomach cancer	0.000199	0.00211	CcSEcCtD
Mianserin—Confusional state—Capecitabine—stomach cancer	0.000198	0.00211	CcSEcCtD
Mianserin—Tachycardia—Docetaxel—stomach cancer	0.000198	0.00211	CcSEcCtD
Mianserin—Skin disorder—Docetaxel—stomach cancer	0.000197	0.0021	CcSEcCtD
Mianserin—Oedema—Capecitabine—stomach cancer	0.000196	0.00209	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—stomach cancer	0.000196	0.00209	CcSEcCtD
Mianserin—Dizziness—Irinotecan—stomach cancer	0.000194	0.00207	CcSEcCtD
Mianserin—Jaundice—Doxorubicin—stomach cancer	0.000194	0.00206	CcSEcCtD
Mianserin—Shock—Capecitabine—stomach cancer	0.000193	0.00206	CcSEcCtD
Mianserin—Nervous system disorder—Capecitabine—stomach cancer	0.000193	0.00205	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—stomach cancer	0.000193	0.00205	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—stomach cancer	0.000192	0.00205	CcSEcCtD
Mianserin—Thrombocytopenia—Capecitabine—stomach cancer	0.000192	0.00205	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—stomach cancer	0.000192	0.00204	CcSEcCtD
Mianserin—Tachycardia—Capecitabine—stomach cancer	0.000192	0.00204	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—stomach cancer	0.000191	0.00203	CcSEcCtD
Mianserin—Skin disorder—Capecitabine—stomach cancer	0.000191	0.00203	CcSEcCtD
Mianserin—Hypotension—Docetaxel—stomach cancer	0.00019	0.00202	CcSEcCtD
Mianserin—Connective tissue disorder—Epirubicin—stomach cancer	0.000189	0.00202	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000188	0.002	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—stomach cancer	0.000187	0.00199	CcSEcCtD
Mianserin—Dizziness—Fluorouracil—stomach cancer	0.000186	0.00198	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—stomach cancer	0.000186	0.00197	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—stomach cancer	0.000185	0.00197	CcSEcCtD
Mianserin—Rash—Irinotecan—stomach cancer	0.000185	0.00197	CcSEcCtD
Mianserin—Dermatitis—Irinotecan—stomach cancer	0.000185	0.00197	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000185	0.00197	CcSEcCtD
Mianserin—Nortriptyline—HTR1A—stomach cancer	0.000185	0.0592	CrCbGaD
Mianserin—Headache—Irinotecan—stomach cancer	0.000184	0.00196	CcSEcCtD
Mianserin—Hypotension—Capecitabine—stomach cancer	0.000184	0.00195	CcSEcCtD
Mianserin—Paraesthesia—Docetaxel—stomach cancer	0.000182	0.00194	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—stomach cancer	0.000181	0.00193	CcSEcCtD
Mianserin—Somnolence—Docetaxel—stomach cancer	0.00018	0.00192	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—stomach cancer	0.00018	0.00192	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—stomach cancer	0.00018	0.00192	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—stomach cancer	0.00018	0.00191	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000179	0.00191	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—stomach cancer	0.000179	0.0019	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—stomach cancer	0.000178	0.0019	CcSEcCtD
Mianserin—Rash—Fluorouracil—stomach cancer	0.000177	0.00189	CcSEcCtD
Mianserin—Dermatitis—Fluorouracil—stomach cancer	0.000177	0.00189	CcSEcCtD
Mianserin—Paraesthesia—Capecitabine—stomach cancer	0.000176	0.00188	CcSEcCtD
Mianserin—Headache—Fluorouracil—stomach cancer	0.000176	0.00187	CcSEcCtD
Mianserin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000175	0.00186	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000175	0.00186	CcSEcCtD
Mianserin—Desipramine—CYP2A6—stomach cancer	0.000175	0.0561	CrCbGaD
Mianserin—Fatigue—Docetaxel—stomach cancer	0.000175	0.00186	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—stomach cancer	0.000175	0.00186	CcSEcCtD
Mianserin—Trimipramine—HTR1A—stomach cancer	0.000174	0.0557	CrCbGaD
Mianserin—Mediastinal disorder—Epirubicin—stomach cancer	0.000174	0.00185	CcSEcCtD
Mianserin—Constipation—Docetaxel—stomach cancer	0.000174	0.00185	CcSEcCtD
Mianserin—Desipramine—ADRB1—stomach cancer	0.00017	0.0545	CrCbGaD
Mianserin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00017	0.00181	CcSEcCtD
Mianserin—Fatigue—Capecitabine—stomach cancer	0.000169	0.0018	CcSEcCtD
Mianserin—Mental disorder—Epirubicin—stomach cancer	0.000169	0.0018	CcSEcCtD
Mianserin—Constipation—Capecitabine—stomach cancer	0.000168	0.00179	CcSEcCtD
Mianserin—Feeling abnormal—Docetaxel—stomach cancer	0.000167	0.00178	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—stomach cancer	0.000167	0.00177	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—stomach cancer	0.000166	0.00177	CcSEcCtD
Mianserin—Anaemia—Methotrexate—stomach cancer	0.000166	0.00176	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—stomach cancer	0.000165	0.00176	CcSEcCtD
Mianserin—Feeling abnormal—Capecitabine—stomach cancer	0.000162	0.00172	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—stomach cancer	0.000162	0.00172	CcSEcCtD
Mianserin—Vertigo—Methotrexate—stomach cancer	0.000161	0.00171	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000161	0.00171	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—stomach cancer	0.00016	0.00171	CcSEcCtD
Mianserin—Mental disorder—Doxorubicin—stomach cancer	0.000156	0.00166	CcSEcCtD
Mianserin—Convulsion—Methotrexate—stomach cancer	0.000155	0.00165	CcSEcCtD
Mianserin—Anaemia—Epirubicin—stomach cancer	0.000155	0.00165	CcSEcCtD
Mianserin—Agitation—Epirubicin—stomach cancer	0.000154	0.00164	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—stomach cancer	0.000153	0.00162	CcSEcCtD
Mianserin—Myalgia—Methotrexate—stomach cancer	0.000153	0.00162	CcSEcCtD
Mianserin—Desipramine—HTR1A—stomach cancer	0.000152	0.0487	CrCbGaD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000152	0.00161	CcSEcCtD
Mianserin—Vertigo—Epirubicin—stomach cancer	0.000151	0.0016	CcSEcCtD
Mianserin—Syncope—Epirubicin—stomach cancer	0.00015	0.0016	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—stomach cancer	0.00015	0.0016	CcSEcCtD
Mianserin—Oxcarbazepine—ALB—stomach cancer	0.000148	0.0474	CrCbGaD
Mianserin—Confusional state—Methotrexate—stomach cancer	0.000147	0.00157	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—stomach cancer	0.000147	0.00157	CcSEcCtD
Mianserin—Asthenia—Docetaxel—stomach cancer	0.000146	0.00155	CcSEcCtD
Mianserin—Convulsion—Epirubicin—stomach cancer	0.000145	0.00155	CcSEcCtD
Mianserin—Hypertension—Epirubicin—stomach cancer	0.000145	0.00154	CcSEcCtD
Mianserin—Pruritus—Docetaxel—stomach cancer	0.000144	0.00153	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—stomach cancer	0.000143	0.00153	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—stomach cancer	0.000143	0.00153	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—stomach cancer	0.000143	0.00152	CcSEcCtD
Mianserin—Desipramine—ADRB2—stomach cancer	0.000143	0.0458	CrCbGaD
Mianserin—Arthralgia—Epirubicin—stomach cancer	0.000143	0.00152	CcSEcCtD
Mianserin—Myalgia—Epirubicin—stomach cancer	0.000143	0.00152	CcSEcCtD
Mianserin—Agitation—Doxorubicin—stomach cancer	0.000143	0.00152	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—stomach cancer	0.000142	0.00151	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000142	0.00151	CcSEcCtD
Mianserin—Asthenia—Capecitabine—stomach cancer	0.000141	0.0015	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—stomach cancer	0.00014	0.00149	CcSEcCtD
Mianserin—CYP3A4—Irinotecan—stomach cancer	0.000139	0.1	CbGbCtD
Mianserin—Vertigo—Doxorubicin—stomach cancer	0.000139	0.00148	CcSEcCtD
Mianserin—Syncope—Doxorubicin—stomach cancer	0.000139	0.00148	CcSEcCtD
Mianserin—Pruritus—Capecitabine—stomach cancer	0.000139	0.00148	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—stomach cancer	0.000139	0.00148	CcSEcCtD
Mianserin—Confusional state—Epirubicin—stomach cancer	0.000138	0.00147	CcSEcCtD
Mianserin—Oedema—Epirubicin—stomach cancer	0.000137	0.00146	CcSEcCtD
Mianserin—Hypotension—Methotrexate—stomach cancer	0.000137	0.00145	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—stomach cancer	0.000136	0.00145	CcSEcCtD
Mianserin—Shock—Epirubicin—stomach cancer	0.000135	0.00143	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—stomach cancer	0.000134	0.00143	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—stomach cancer	0.000134	0.00143	CcSEcCtD
Mianserin—Dizziness—Docetaxel—stomach cancer	0.000134	0.00143	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—stomach cancer	0.000134	0.00143	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—stomach cancer	0.000134	0.00143	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—stomach cancer	0.000134	0.00142	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000133	0.00142	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—stomach cancer	0.000133	0.00142	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—stomach cancer	0.000132	0.00141	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—stomach cancer	0.000132	0.00141	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—stomach cancer	0.000131	0.0014	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000131	0.0014	CcSEcCtD
Mianserin—Somnolence—Methotrexate—stomach cancer	0.00013	0.00138	CcSEcCtD
Mianserin—Dizziness—Capecitabine—stomach cancer	0.00013	0.00138	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—stomach cancer	0.000129	0.00138	CcSEcCtD
Mianserin—Imipramine—HTR1A—stomach cancer	0.000129	0.0413	CrCbGaD
Mianserin—Amitriptyline—HTR1A—stomach cancer	0.000128	0.0411	CrCbGaD
Mianserin—Rash—Docetaxel—stomach cancer	0.000128	0.00136	CcSEcCtD
Mianserin—Hypotension—Epirubicin—stomach cancer	0.000128	0.00136	CcSEcCtD
Mianserin—Dermatitis—Docetaxel—stomach cancer	0.000128	0.00136	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—stomach cancer	0.000128	0.00136	CcSEcCtD
Mianserin—Headache—Docetaxel—stomach cancer	0.000127	0.00135	CcSEcCtD
Mianserin—Oedema—Doxorubicin—stomach cancer	0.000127	0.00135	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000126	0.00134	CcSEcCtD
Mianserin—Fatigue—Methotrexate—stomach cancer	0.000126	0.00134	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000125	0.00133	CcSEcCtD
Mianserin—Shock—Doxorubicin—stomach cancer	0.000125	0.00133	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—stomach cancer	0.000124	0.00132	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000124	0.00132	CcSEcCtD
Mianserin—Rash—Capecitabine—stomach cancer	0.000124	0.00132	CcSEcCtD
Mianserin—Dermatitis—Capecitabine—stomach cancer	0.000124	0.00132	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—stomach cancer	0.000124	0.00132	CcSEcCtD
Mianserin—Headache—Capecitabine—stomach cancer	0.000123	0.00131	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—stomach cancer	0.000123	0.00131	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—stomach cancer	0.000123	0.00131	CcSEcCtD
Mianserin—Somnolence—Epirubicin—stomach cancer	0.000122	0.0013	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—stomach cancer	0.000121	0.00128	CcSEcCtD
Mianserin—CYP2D6—Doxorubicin—stomach cancer	0.00012	0.0859	CbGbCtD
Mianserin—Hypotension—Doxorubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Mianserin—Fatigue—Epirubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Mianserin—Constipation—Epirubicin—stomach cancer	0.000117	0.00125	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000115	0.00123	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—stomach cancer	0.000114	0.00121	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—stomach cancer	0.000113	0.0012	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—stomach cancer	0.000113	0.0012	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000109	0.00116	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—stomach cancer	0.000109	0.00116	CcSEcCtD
Mianserin—Constipation—Doxorubicin—stomach cancer	0.000108	0.00115	CcSEcCtD
Mianserin—Asthenia—Methotrexate—stomach cancer	0.000105	0.00112	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—stomach cancer	0.000104	0.00111	CcSEcCtD
Mianserin—Pruritus—Methotrexate—stomach cancer	0.000103	0.0011	CcSEcCtD
Mianserin—CYP3A4—Docetaxel—stomach cancer	0.000102	0.0733	CbGbCtD
Mianserin—Asthenia—Epirubicin—stomach cancer	9.82e-05	0.00105	CcSEcCtD
Mianserin—Pruritus—Epirubicin—stomach cancer	9.68e-05	0.00103	CcSEcCtD
Mianserin—Dizziness—Methotrexate—stomach cancer	9.67e-05	0.00103	CcSEcCtD
Mianserin—Rash—Methotrexate—stomach cancer	9.22e-05	0.000982	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—stomach cancer	9.21e-05	0.000981	CcSEcCtD
Mianserin—Headache—Methotrexate—stomach cancer	9.16e-05	0.000975	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—stomach cancer	9.09e-05	0.000967	CcSEcCtD
Mianserin—Dizziness—Epirubicin—stomach cancer	9.05e-05	0.000963	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—stomach cancer	8.96e-05	0.000954	CcSEcCtD
Mianserin—Rash—Epirubicin—stomach cancer	8.63e-05	0.000919	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—stomach cancer	8.62e-05	0.000918	CcSEcCtD
Mianserin—Headache—Epirubicin—stomach cancer	8.58e-05	0.000913	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—stomach cancer	8.38e-05	0.000891	CcSEcCtD
Mianserin—Nortriptyline—ALB—stomach cancer	8.29e-05	0.0266	CrCbGaD
Mianserin—Rash—Doxorubicin—stomach cancer	7.99e-05	0.00085	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—stomach cancer	7.98e-05	0.000849	CcSEcCtD
Mianserin—Headache—Doxorubicin—stomach cancer	7.93e-05	0.000844	CcSEcCtD
Mianserin—CYP3A4—Doxorubicin—stomach cancer	7.62e-05	0.0546	CbGbCtD
Mianserin—Amitriptyline—ALB—stomach cancer	5.75e-05	0.0184	CrCbGaD
Mianserin—HTR1D—Signaling Pathways—MAPK1—stomach cancer	3.13e-06	2.5e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—stomach cancer	3.13e-06	2.5e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	3.12e-06	2.49e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—stomach cancer	3.11e-06	2.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	3.1e-06	2.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	3.1e-06	2.48e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—stomach cancer	3.1e-06	2.48e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	3.1e-06	2.47e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—stomach cancer	3.09e-06	2.47e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	3.09e-06	2.46e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCND1—stomach cancer	3.08e-06	2.46e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—JUN—stomach cancer	3.07e-06	2.45e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	3.07e-06	2.45e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TYMS—stomach cancer	3.06e-06	2.45e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CD44—stomach cancer	3.05e-06	2.43e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.03e-06	2.42e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTM1—stomach cancer	3.03e-06	2.42e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.02e-06	2.41e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—KRAS—stomach cancer	3.02e-06	2.41e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—stomach cancer	3.02e-06	2.41e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	3.01e-06	2.41e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	3.01e-06	2.4e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.99e-06	2.39e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.98e-06	2.38e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—KRAS—stomach cancer	2.98e-06	2.38e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—stomach cancer	2.97e-06	2.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—KRAS—stomach cancer	2.97e-06	2.37e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCND1—stomach cancer	2.97e-06	2.37e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—JUN—stomach cancer	2.97e-06	2.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.97e-06	2.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.96e-06	2.36e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	2.96e-06	2.36e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCND1—stomach cancer	2.96e-06	2.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB2—stomach cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—KRAS—stomach cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—JUN—stomach cancer	2.95e-06	2.36e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—stomach cancer	2.94e-06	2.35e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—stomach cancer	2.94e-06	2.35e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2.94e-06	2.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.93e-06	2.34e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAV1—stomach cancer	2.91e-06	2.33e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOA1—stomach cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB2—stomach cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB2—stomach cancer	2.9e-06	2.32e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—stomach cancer	2.9e-06	2.31e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—stomach cancer	2.89e-06	2.3e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCND1—stomach cancer	2.88e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK1—stomach cancer	2.88e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—stomach cancer	2.88e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	2.88e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—stomach cancer	2.87e-06	2.29e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—JUN—stomach cancer	2.87e-06	2.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	2.86e-06	2.28e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2.86e-06	2.28e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ERCC2—stomach cancer	2.85e-06	2.27e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—stomach cancer	2.83e-06	2.26e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK3—stomach cancer	2.81e-06	2.25e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK8—stomach cancer	2.81e-06	2.24e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—stomach cancer	2.8e-06	2.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—stomach cancer	2.79e-06	2.23e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK8—stomach cancer	2.79e-06	2.23e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HRAS—stomach cancer	2.78e-06	2.22e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	2.78e-06	2.22e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	2.77e-06	2.22e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—stomach cancer	2.76e-06	2.2e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—stomach cancer	2.75e-06	2.2e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—HRAS—stomach cancer	2.74e-06	2.19e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—stomach cancer	2.74e-06	2.18e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1B—stomach cancer	2.74e-06	2.18e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PIK3CA—stomach cancer	2.73e-06	2.18e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HRAS—stomach cancer	2.73e-06	2.18e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—stomach cancer	2.73e-06	2.18e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—stomach cancer	2.72e-06	2.17e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	2.72e-06	2.17e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	2.71e-06	2.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	2.69e-06	2.15e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	2.69e-06	2.15e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1B—stomach cancer	2.69e-06	2.14e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—stomach cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK1—stomach cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—stomach cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—stomach cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—stomach cancer	2.66e-06	2.13e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—stomach cancer	2.66e-06	2.12e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—stomach cancer	2.64e-06	2.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	2.64e-06	2.11e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—stomach cancer	2.64e-06	2.11e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—stomach cancer	2.62e-06	2.1e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—stomach cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—stomach cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCND1—stomach cancer	2.61e-06	2.08e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—JUN—stomach cancer	2.6e-06	2.08e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.59e-06	2.07e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.59e-06	2.07e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.58e-06	2.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.57e-06	2.05e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HRAS—stomach cancer	2.57e-06	2.05e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.57e-06	2.05e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—JUN—stomach cancer	2.56e-06	2.05e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCND1—stomach cancer	2.56e-06	2.05e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—stomach cancer	2.56e-06	2.05e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—JUN—stomach cancer	2.56e-06	2.04e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.55e-06	2.04e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—stomach cancer	2.54e-06	2.03e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.54e-06	2.03e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—stomach cancer	2.53e-06	2.02e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HRAS—stomach cancer	2.53e-06	2.02e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—stomach cancer	2.53e-06	2.02e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HRAS—stomach cancer	2.53e-06	2.02e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.52e-06	2.02e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HRAS—stomach cancer	2.51e-06	2e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—stomach cancer	2.51e-06	2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.51e-06	2e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.51e-06	2e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.5e-06	1.99e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.49e-06	1.99e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.49e-06	1.99e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—stomach cancer	2.49e-06	1.99e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.48e-06	1.98e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.48e-06	1.98e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.48e-06	1.98e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.47e-06	1.97e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—stomach cancer	2.47e-06	1.97e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.46e-06	1.97e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOA1—stomach cancer	2.46e-06	1.97e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—stomach cancer	2.46e-06	1.96e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.45e-06	1.96e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.45e-06	1.96e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.44e-06	1.95e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.42e-06	1.94e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—stomach cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—stomach cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—stomach cancer	2.41e-06	1.93e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—stomach cancer	2.4e-06	1.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.38e-06	1.9e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—stomach cancer	2.38e-06	1.9e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.37e-06	1.89e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—stomach cancer	2.37e-06	1.89e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TYMS—stomach cancer	2.36e-06	1.89e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.36e-06	1.88e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.34e-06	1.87e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.34e-06	1.87e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.34e-06	1.87e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.33e-06	1.86e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.33e-06	1.86e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.33e-06	1.86e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—stomach cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.31e-06	1.84e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.31e-06	1.84e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—stomach cancer	2.3e-06	1.84e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.28e-06	1.82e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.27e-06	1.82e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.27e-06	1.81e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.26e-06	1.8e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2.26e-06	1.8e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2.26e-06	1.8e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—stomach cancer	2.25e-06	1.8e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—stomach cancer	2.25e-06	1.79e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.24e-06	1.79e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.23e-06	1.78e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.22e-06	1.77e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—stomach cancer	2.21e-06	1.77e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—stomach cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—stomach cancer	2.2e-06	1.76e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.2e-06	1.76e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.19e-06	1.75e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—stomach cancer	2.17e-06	1.73e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.15e-06	1.72e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRAS—stomach cancer	2.15e-06	1.72e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—stomach cancer	2.13e-06	1.7e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.12e-06	1.69e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.11e-06	1.69e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	2.1e-06	1.67e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—stomach cancer	2.09e-06	1.67e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.06e-06	1.65e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—stomach cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—stomach cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—stomach cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.05e-06	1.64e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—stomach cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.04e-06	1.63e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—stomach cancer	2.03e-06	1.62e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.02e-06	1.62e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.02e-06	1.61e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—stomach cancer	2.01e-06	1.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—stomach cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—stomach cancer	1.95e-06	1.56e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—stomach cancer	1.95e-06	1.56e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.94e-06	1.55e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—stomach cancer	1.93e-06	1.54e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.93e-06	1.54e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—stomach cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—stomach cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOA1—stomach cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—stomach cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.89e-06	1.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.87e-06	1.5e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.87e-06	1.5e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—stomach cancer	1.87e-06	1.49e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRAS—stomach cancer	1.86e-06	1.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.86e-06	1.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—stomach cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—stomach cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—stomach cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—stomach cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—stomach cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—stomach cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—stomach cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—stomach cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRAS—stomach cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRAS—stomach cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—stomach cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—stomach cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—stomach cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—stomach cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—stomach cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.24e-06	9.9e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.05e-06	8.38e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.1e-07	6.47e-06	CbGpPWpGaD
